AURORA CANNABIS INC Logo

AURORA CANNABIS INC

A global producer and seller of medical and recreational cannabis and derivative products.

ACB | US

Overview

Corporate Details

ISIN(s):
CA05156X8843
LEI:
Country:
United States of America
Address:
2207 90B STREET SW, EDMONTON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Aurora Cannabis Inc. is a Canadian-licensed company engaged in the production, distribution, and sale of medical and recreational cannabis and cannabis-derivative products. The company's operations span multiple continents, offering a diverse portfolio that includes dried cannabis, cannabis oils, and various consumer products under brands such as Aurora, Aurora Drift, San Rafael '71, and Daily Special. Aurora focuses on the entire value chain, from cultivation and production to patient education and sales, with a particular emphasis on science-based medical cannabis solutions for the Canadian and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AURORA CANNABIS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AURORA CANNABIS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AURORA CANNABIS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NeuroSense Therapeutics Ltd. Logo
Developing combination therapies for neurodegenerative diseases, with a focus on ALS.
United States of America NRSN
NewAmsterdam Pharma Co N.V. Logo
Developing oral LDL-lowering therapies for high-risk cardiovascular disease patients.
United States of America NAMS
Newbury Pharmaceuticals AB Logo
Develops specialty prescription drugs for Scandinavia in oncology, rare diseases & neurology.
Sweden NEWBRY
New Nordic Healthbrands AB Logo
Develops and markets herbal supplements & beauty products for natural wellness consumers globally.
Sweden NNH
Newron Pharmaceuticals S.p.A. Logo
Biopharma developing novel therapies for nervous system diseases like Parkinson's and schizophrenia.
Italy NWRN
NEXGEL, INC. Logo
Develops and manufactures advanced hydrogels for healthcare, OTC, and consumer applications.
United States of America NXGL
NextCell Pharma AB Logo
Develops off-the-shelf cell therapies for autoimmune diseases like type 1 diabetes.
Sweden NXTCL
NextCure, Inc. Logo
Clinical-stage biopharma developing novel immunomedicines for cancer and other diseases.
United States of America NXTC
NGeneBio Co., Ltd. Logo
Provides NGS-based diagnostics, software, and liquid biopsy for precision oncology and healthcare.
South Korea 354200
NIBEC CO., LTD. Logo
Biotech CDMO creating regenerative products with peptide and biomaterial technologies.
South Korea 138610

Talk to a Data Expert

Have a question? We'll get back to you promptly.